DIA会员及用户请点击登录

登录

忘记用户 ID? or 忘记密码?

Not a Member?

创建账户并加入。

Hyatt Regency Bethesda

2017 年 10 月 24 日 7:00 上午 - 2017 年 10 月 25 日 3:30 下午

One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814-5326

Biosimilars Conference

Session 5: Penetrating the Market

Session Chair(s)

Juliana Marguerite Reed, MS

Juliana Marguerite Reed, MS

Executive Director

The Biosimilars Forum, United States

As the number of approved biosimilars in the US marketplace increases, understanding the perspectives and needs of the patient, payer, and prescriber are key requirements to ensure the successful uptake of biosimilars. This session will explore those perspectives and ways to address the needs of these important stakeholders.

Learning Objective :
  • Provide an overview of where biosimilars started in Europe and where they are today
  • Provide an overview of lessons learned and recommendations in Europe
  • Provide physician, patient, and payor/PBM perspectives on needs and requirements for the successful uptake of biosimilars.
  • Provide an update on the FDA’s efforts to educate stakeholders on biosimilars

Speaker(s)

Suzette  Kox, MPharm

Speaker

Suzette Kox, MPharm

Medicines for Europe, Belgium

Senior Director International-Biosimilars Medicines Group

Angus  Worthing, MD

Speaker

Angus Worthing, MD

American College of Rheumatology, United States

Chair, Government Affairs Committee

Leah  Howard, JD

Speaker

Leah Howard, JD

National Psoriasis Foundation, United States

Vice President, Government Relations and Advocacy

Chris  Davis

Speaker

Chris Davis

Express Scripts, United States

Director, Government Affairs

Sarah  Crowley-Ikenberry, MA

Speaker

Sarah Crowley-Ikenberry, MA

FDA, United States

Senior Communication Advisor, OTBB, OND, CDER

Cheryl  Schwartz

Speaker

Cheryl Schwartz

Pfizer, Inc., United States

General Manager, US Biosimilars

Tânia  Teixeira, PharmD

Speaker

Tânia Teixeira, PharmD

European Medicines Agency, United States

EMA Official at the FDA

获得信息并保持参与

不要错失任何机会——请加入我们的邮件列表,了解DIA的观点和事件。